ArticleJournal of clinical medicine2025

Focusing on Selinexor for Holding and Bridging Prior to CAR-T in Relapsed/Refractory Multiple Myeloma.

Jack Khouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.